×
About 6,793 results

ALLMedicine™ Acinetobacter Center

Research & Reviews  2,333 results

Factors influencing environmental sampling recovery of healthcare pathogens from non-po...
https://doi.org/10.1371/journal.pone.0261588
PloS One; Rose LJ, Houston H et. al.

Jan 14th, 2022 - Results from sampling healthcare surfaces for pathogens are difficult to interpret without understanding the factors that influence pathogen detection. We investigated the recovery of four healthcare-associated pathogens from three common surface ...

Prevalence, Pattern, Risks Factors and Consequences of Antibiotic Resistance in COPD: A...
https://doi.org/10.1080/15412555.2021.2000957
COPD Smith D, Gill A et. al.

Jan 13th, 2022 - A concern of antibiotic use in chronic obstructive pulmonary disease (COPD) is the emergence and propagation of antimicrobial resistance (AMR). A systematic review was conducted to determine prevalence, pattern, risk factors and consequences of AM...

Treatment, clinical outcomes, and predictors of mortality among a national cohort of ad...
https://doi.org/10.1128/AAC.01975-21
Antimicrobial Agents and Chemotherapy; Appaneal HJ, Lopes VV et. al.

Jan 11th, 2022 - Objectives: To analyze treatment, clinical outcomes, and predictors of mortality in hospitalized patients with Acinetobacter baumannii infection. Methods: Retrospective cohort study of inpatients with A. baumannii cultures and treatment from 2010-...

Cleaning and disinfecting surfaces in hospitals and long-term care facilities for reduc...
https://doi.org/10.1016/j.jhin.2021.12.017
The Journal of Hospital Infection; Thomas RE, Thomas BC et. al.

Jan 10th, 2022 - Multiply drug-resistant organisms (MDROs) in hospitals and long-term care facilities (LTCFs) of particular concern include meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococcus, multidrug-resistant Acinetobacter spec...

The characteristic and potential therapeutic effect of isolated multidrug-resistant Aci...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742398
Annals of Clinical Microbiology and Antimicrobials; Sisakhtpour B, Mirzaei A et. al.

Jan 9th, 2022 - Widespread misuse of antibiotics caused bacterial resistance increasingly become a serious threat. Bacteriophage therapy promises alternative treatment strategies for combatting drug-resistant bacterial infections. In this study, we isolated and c...

see more →

Guidelines  3 results

Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985752
Antimicrobial Agents and Chemotherapy; Pogue JM, Jones RN et. al.

Nov 27th, 2019 - The polymyxins are important agents for carbapenem-resistant Gram-negative bacilli. The United States Committee on Antimicrobial Susceptibility Testing breakpoint recommendations for colistin and polymyxin B are that isolates of Pseudomonas aerugi...

Task force on management and prevention of Acinetobacter baumannii infections in the ICU.
https://doi.org/10.1007/s00134-015-4079-4
Intensive Care Medicine; Garnacho-Montero J, Dimopoulos G et. al.

Oct 7th, 2015 - Acinetobacter baumannii constitutes a dreadful problem in many ICUs worldwide. The very limited therapeutic options available for these organisms are a matter of great concern. No specific guidelines exist addressing the prevention and management ...

Preventing catheter-associated urinary tract infections: An executive summary of the As...
https://doi.org/10.1016/j.ajic.2010.08.003
American Journal of Infection Control; Rebmann T, Greene LR

Sep 28th, 2010 - The Association for Professionals in Infection Control and Epidemiology (APIC) began publishing their series of Elimination Guides in 2007. Since then, 9 Elimination Guides have been developed that cover a range of important infection prevention i...

see more →

Drugs  256 results see all →

Clinicaltrials.gov  24 results

RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI
https://clinicaltrials.gov/ct2/show/NCT03869437

Dec 9th, 2021 - Infections with antibiotic resistant bacteria cause a significant burden of disease worldwide. Bloodstream infections may arise from a variety of sources, are commonly encountered in clinical practice, and are associated with significant morbidity...

Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
https://clinicaltrials.gov/ct2/show/NCT01597973

Nov 30th, 2021 - The Gram-negative bacilli organisms Acinetobacter baumannii, Klebsiella spp., Escherichia coli, Enterobacter spp. and Pseudomonas aeruginosa have become a frequent cause of bloodstream infection and pneumonia in the hospital and other healthcare s...

7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated Pneumonia
https://clinicaltrials.gov/ct2/show/NCT03477292

Aug 3rd, 2021 - Ventilator-associated pneumonia (VAP) is one of the major causes of morbidity and mortality in the ICU, accounting for 25% of the total infections occurring in this setting and 50% of all antibiotic prescriptions in patients who are mechanically v...

In Vitro Activity of Ceftolozane-tazobactam Against Contemporary Nosocomial Gram "-" Pathogens Isolated in Russia
https://clinicaltrials.gov/ct2/show/NCT04679610

Dec 22nd, 2020 - Infections caused by resistant gram-negative bacteria are becoming increasingly prevalent and now constitute a serious threat to public health worldwide because they are difficult to treat and are associated with high morbidity and mortality rates...

Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
https://clinicaltrials.gov/ct2/show/NCT04291768

Nov 19th, 2020 - Introduction: Prolonged use of antibiotics is closely related to antibiotic-associated infections, anti-microbial resistance and adverse drug events. The optimal duration of antibiotic treatment for Gram-negative bacteremia (GNB) with a urinary tr...

see more →

News  101 results

FDA Approval Insights: Daratumumab / Carfilzomib / Dexamethasone in Myeloma
https://www.onclive.com/view/fda-approval-insights-daratumumab-carfilzomib-dexamethasone-in-myeloma

Aug 17th, 2021 - Welcome to OncLive On Air™! I’m your host today, Jessica Hergert. OncLive On Air™ is a podcast from OncLive, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital an...

CDC Doc Addresses Today's Pandemic and the Next
https://www.medscape.com/viewarticle/941169

Nov 23rd, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. On July 1, 2020, when I began a rotation on the infectious disease consult service at the Veterans Administration Hospital in Atlanta, we had three patients with...

Trending Clinical Topic: Sepsis
https://reference.staging.medscape.com/viewarticle/924389

Feb 7th, 2020 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, feel free to share them with us on Twitter or Facebook. ...

Threat of Antibiotic Resistance in US Higher Than Thought, CDC Says
https://www.staging.medscape.com/viewarticle/921293

Nov 13th, 2019 - Antibiotic resistance is a greater threat in the United States than previously estimated and is not going away, according to the US Centers for Disease Control and Prevention (CDC) in a report released today. Each year, antibiotic-resistant bacter...

Multidrug-Resistant Bacteria Found on Patient Hands, Surfaces
https://www.medscape.com/viewarticle/911880

Apr 16th, 2019 - Multidrug-resistant organisms (MDROs), or "superbugs," are commonly found on hospitalized patients' hands, investigators report. The researchers found that 13. 3% of patients had MDROs on their hands and that 39 They cautioned in a press release t...

see more →